Pink1 and mtf2 modulators synergize cell transplantation therapy in parkinsons disease

HIGHLIGHTS

• What: To test the conclusions , the authors propose a co-transplantation experiment, combining MTK458 with human iPSC derived DANs to be transplanted in PD modeled mice. This study shows a range of implications for DAN transplantation therapy. This study has demonstrated a new strategy of enhancing DAN survival in transplantation to the midbrain by modulating PINK1 pathway .
• Who: Yichen Gao from the United World College Changshu China, Jiangsu, China have published the paper: PINK1 and MTF2 Modulators Synergize Cell Transplantation Therapy in Parkinson’s Disease, in the : Proceedings of the 4th International Conference on Biological . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.